Compile Data Set for Download or QSAR
Report error Found 128 Enz. Inhib. hit(s) with all data for entry = 6396
TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126609BDBM126609(US8772283, 53)
Affinity DataIC50: 0.260nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126581BDBM126581(US8772283, 25)
Affinity DataIC50: 0.270nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126608BDBM126608(US8772283, 52)
Affinity DataIC50: 0.280nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126557BDBM126557(US8772283, 1)
Affinity DataIC50: 0.290nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126578BDBM126578(US8772283, 22)
Affinity DataIC50: 0.300nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126611BDBM126611(US8772283, 55)
Affinity DataIC50: 0.310nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126604BDBM126604(US8772283, 48)
Affinity DataIC50: 0.320nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126572BDBM126572(US8772283, 16)
Affinity DataIC50: 0.350nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126618BDBM126618(US8772283, 62)
Affinity DataIC50: 0.400nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126617BDBM126617(US8772283, 61)
Affinity DataIC50: 0.400nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126605BDBM126605(US8772283, 49)
Affinity DataIC50: 0.420nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126591BDBM126591(US8772283, 35)
Affinity DataIC50: 0.480nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126612BDBM126612(US8772283, 56)
Affinity DataIC50: 0.490nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126558BDBM126558(US8772283, 2)
Affinity DataIC50: 0.5nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126615BDBM126615(US8772283, 59)
Affinity DataIC50: 0.530nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126600BDBM126600(US8772283, 44)
Affinity DataIC50: 0.550nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126616BDBM126616(US8772283, 60)
Affinity DataIC50: 0.570nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126574BDBM126574(US8772283, 18)
Affinity DataIC50: 0.600nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126614BDBM126614(US8772283, 58)
Affinity DataIC50: 0.700nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126560BDBM126560(US8772283, 4)
Affinity DataIC50: 0.710nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126592BDBM126592(US8772283, 36)
Affinity DataIC50: 0.740nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126576BDBM126576(US8772283, 20)
Affinity DataIC50: 0.75nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126587BDBM126587(US8772283, 31)
Affinity DataIC50: 0.780nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126604BDBM126604(US8772283, 48)
Affinity DataIC50: 0.800nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126606BDBM126606(US8772283, 50)
Affinity DataIC50: 0.850nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126562BDBM126562(US8772283, 6)
Affinity DataIC50: 0.910nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126594BDBM126594(US8772283, 38)
Affinity DataIC50: 0.910nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126561BDBM126561(US8772283, 5)
Affinity DataIC50: 0.910nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126577BDBM126577(US8772283, 21)
Affinity DataIC50: 0.910nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126619BDBM126619(US8772283, 63)
Affinity DataIC50: 0.910nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126620BDBM126620(US8772283, 64)
Affinity DataIC50: 0.940nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126595BDBM126595(US8772283, 39)
Affinity DataIC50: 0.970nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126603BDBM126603(US8772283, 46)
Affinity DataIC50: 0.970nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126564BDBM126564(US8772283, 8)
Affinity DataIC50: 1nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126567BDBM126567(US8772283, 11)
Affinity DataIC50: 1nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126563BDBM126563(US8772283, 7)
Affinity DataIC50: 1.10nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126593BDBM126593(US8772283, 37)
Affinity DataIC50: 1.10nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126588BDBM126588(US8772283, 32)
Affinity DataIC50: 1.10nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126607BDBM126607(US8772283, 51)
Affinity DataIC50: 1.10nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126602BDBM126602(US8772283, 47)
Affinity DataIC50: 1.20nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126559BDBM126559(US8772283, 3)
Affinity DataIC50: 1.20nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126610BDBM126610(US8772283, 54)
Affinity DataIC50: 1.30nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126618BDBM126618(US8772283, 62)
Affinity DataIC50: 1.30nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126605BDBM126605(US8772283, 49)
Affinity DataIC50: 1.30nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126595BDBM126595(US8772283, 39)
Affinity DataIC50: 1.40nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126594BDBM126594(US8772283, 38)
Affinity DataIC50: 1.40nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126566BDBM126566(US8772283, 10)
Affinity DataIC50: 1.40nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126582BDBM126582(US8772283, 26)
Affinity DataIC50: 1.5nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126608BDBM126608(US8772283, 52)
Affinity DataIC50: 1.5nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetRAC-beta serine/threonine-protein kinase(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 126596BDBM126596(US8772283, 40)
Affinity DataIC50: 1.60nMpH: 7.5Assay Description:Preparation of AKT1 and AKT2 and measurement of in vitro inhibitory activity of the above-mentioned compounds against AKT1 and AKT2 kinase activity w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

Displayed 1 to 50 (of 128 total ) | Next | Last >>
Jump to: